Cryonic Medical

11/06/2026

10/06/2026

🚀 CryoScreen continues its development in Brazil

Yesterday, Anne-Sophie delivered a two-hour remote training session to the team of , our distributor in Brazil.

This was an important step to strengthen the team’s practical knowledge of CryoScreen, share best practices, and support our local partner in the commercial deployment of the device.

The Dorja team was highly engaged and enthusiastic throughout the session. This is exactly the kind of collaboration that turns regulatory approval into a real market presence.

Following the successful market authorization of CryoScreen by ANVISA, this training marks another concrete milestone in our development in Brazil.

Thank you to the Dorja team for their commitment and trust.
We are looking forward to the next steps — and to the next orders.

27/05/2026

25/05/2026

19/05/2026

🇧🇷 Exciting milestone for Cryonic Medical!

Following the recent ANVISA homologation of our CryoScreen medical device, we are proud to announce that CryoScreen will be presented for the very first time to the Brazilian market during Hospitalar 2026, one of the largest healthcare and medical technology events in Latin America.

📍 São Paulo, Brazil
📅 May 19–22, 2026

Together with our Brazilian partner Dorja Equipamentos Médicos, we will showcase how CryoScreen is bringing a new generation of precise, non-invasive localized cryotherapy solutions to healthcare professionals and patients.

This important step marks the beginning of Cryonic Medical’s expansion into the Brazilian healthcare market and reinforces our commitment to delivering innovative medical technologies internationally.

A special thank you to all partners, distributors, regulatory teams and healthcare professionals who contributed to making this milestone possible.

We look forward to meeting healthcare professionals, distributors and partners at Hospitalar 2026.

18/05/2026

22/04/2026

08/04/2026

🚀 Major milestone for Cryonic Medical!

We are proud to announce that CryoScreen has officially obtained Anvisa certification, enabling us to enter the Brazilian market.

This achievement marks a significant step in our international expansion and reflects the robustness, safety, and clinical value of our technology.

Brazil represents a key market with strong demand for innovative, non-invasive solutions in pain management and rehabilitation. We are excited to bring CryoScreen to healthcare professionals and patients across the country.

A special thank you to all teams and partners involved in making this possible—your dedication made the difference.

We are also looking forward to building a strong and successful journey with our local partner https://www.instagram.com/dorjaindustria/ https://www.facebook.com/dorjamedicate.

🌍 The journey continues.

01/04/2026

Huge congratulations to the team — and especially to Filomena Falcone — for the outstanding presentation of CryoScreen at the Medicol 2026 congress in Lausanne!
It’s fantastic to see CryoScreen showcased so effectively in close interaction with both hand and shoulder surgery specialists. Demonstrating its anti-inflammatory and anesthetic capabilities in such demanding clinical environments truly reinforces its relevance and impact.
Thank you for your energy, commitment, and for bringing CryoScreen closer to top-tier medical experts!

31/03/2026

🔥 Great news from KIMES 2026!

CryoScreen had a fantastic show in Seoul 🇰🇷

Over 4 days:
👉 Hundreds of visitors engaged with our solution
👉 Strong interest from physiotherapists and medical professionals
👉 High-quality discussions with international buyers

The feedback was clear: the market is ready, and the demand is real.

This is a strong validation of CryoScreen’s positioning and a great step forward in our international development 🚀

Big thanks to our partners and everyone who visited us!